1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6EA98F5DAC4108320652582100041240F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-establishing-effective-medical-affairs-group-capabilities-emerging-countries-tmea-structure-staffing-responsibilities
18
19
203.209.80.217
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Medical Affairs Structure, Staffing and Budgets

Best Practices in Establishing Medical Affairs Capabilities in Emerging Countries: Using Structure, Staffing, and Responsibilities to Create an Effective Medical Affairs Group in TMEA

ID: POP-289


Features:

9 Info Graphics

34 Data Graphics

530+ Metrics


Pages: 53


Published: 2018


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
With pharmaceutical companies facing diverse markets around the world, it is challenging to create and maintain an effective Medical Affairs group in less understood regions such as TMEA, which includes Turkey, Middle East, and South Africa. Consequently, regional and country-level leaders seek to understand the optimal Medical Affairs structure, staffing and responsibilities required to ensure success in the TMEA region.

Best Practices, LLC undertook benchmarking research to identify the requirements for establishing effective Medical Affairs capabilities in the TMEA region. This report will serve as a reference for pharmaceutical organizations to see how their regional and/or country-level Medical Affairs groups compare with industry trends and averages.

Industries Profiled:
Pharmaceutical; Biotech; Chemical; Health Care; Medical Device; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; AstraZeneca; Celgene; Gilead Sciences; Janssen; Novartis; Pfizer; Roche; Sanofi; Takeda Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 11 Medical Affairs executives from 10 leading pharmaceutical companies with operations in the TMEA region. Almost half of the research partners serve as Directors or Heads of Medical Affairs function in TMEA region.

Key topics covered in this report include
:

  • Medical Affairs Responsibilities
  • Country-Level Medical Affairs Structure, Staffing and Activities
  • Field-Based Medical Staff Structure &Staffing
  • Field-Based Medical Staff Responsibilities & Compliance
  • Field-Based Medical Staff Performance & Virtual Meetings


Key Findings

Sample key insights uncovered from this report are noted below. Detailed findings are available in the full report.


  • Most Participants Utilize Almost all Key Medical Affairs Functions & Roles in TMEA Region: More than 60% of study participants employ all the key medical affairs functions - except publication & medical writing. Likewise, more than half use medical affairs roles such medical advisors, clinical research, MSLs, medical directors, medical affairs directors, PV/safety training and medical information and call centres.
  • MSLs in TMEA have Scope of Work Similar to Mature Markets: Similar to mature markets, MSLs in the TMEA region have responsibility for 17 key MSL activities. All participants rely on MSLs for KOL management, field-based work, congresses, CI, clinical study support and education programs & symposia.
  • Countries in TMEA have 4 to 6 MSLs, on Average: On average, companies in the study have 4 to 6 MSLs for each of the countries in the TMEA region. For span of control, participants said that each MSL manager is responsible for 5 MSLs, on average.

Table of Contents

I.Executive Summary: Methodology, Participants, Recommendations & Key Findingspgs. 3-10
Study Structure & Design
Universe of Learning: Benchmark Class
Recommendations
II.Benchmark Class Profilepgs. 11-15
Titles
Company Size
Survey Perspective
Structure
III.Medical Affairs Top Activities & Responsibilitiespgs. 16-25
Top Activities
Responsibilities
IV.Affiliate / Country Level Medical Affairspgs. 26-37
Structure
Staffing
Activities
V.Field-Based Staffpgs. 38-41
Structure & Staffing
Launch Activities
Launch Timing
Responsibilities & Compliance
Performance & Virtual Meetings
VI.Field-Based Staff, Responsibilities & Compliancepgs. 42-47
Performance Measurement
Virtual Interactions
Clinical Studies
VII.Field-Based Medical Staff, Measuring Performance & Virtual Interactionspgs. 48-52
Performance Measurement
Virtual Interactions
Clinical Studies

List of Charts & Exhibits

Medical Affairs Top Activities & Responsibilities
  • Primary responsibility for each of the listed medical affairs activities
  • Primary responsibility for each of the listed promotional and non-promotional medical affairs activities
  • Primary responsibility for each of the listed strategy and project management medical affairs activities
  • Primary responsibility for each of the listed KOL management and engagement activities
  • Primary responsibility for each of the listed medical affairs training and support activities
  • Primary responsibility for each of the listed medical affairs safety and compliance activities
  • Primary responsibility for each of the listed clinical research related medical affairs activities
  • Top medical affairs activities that have the greatest positive impact on customers

Affiliate/ Country Level Medical Affairs Structure, Staffing & Activities
  • Current affiliate/country organizational structure of participating companies
  • City in which participants’ affiliate/country office is located
  • Whether affiliate/country office supports neighboring countries?
  • Functions that are part of medical affairs in the affiliate/country level
  • Roles present within affiliate/country medical affairs function
  • Turkey country-level medical affairs structure: one top 10 pharma company
  • UAE country-level medical affairs structure: two top 10 pharma companies
  • Three structural attributes common to medical affairs in TMEA countries
  • Country and regional level breakdown of medical affairs FTE allocation by role
  • Outsourcing of medical affairs activities, activities outsourced and total number of medical affairs staff in affiliate/country offices
  • Product launch activities in which affiliate/country level team takes part in
  • Timing of affiliate/country level teams’ involvement in product launch activities

Field Based Staff: Structure, Staffing & Launch Activities
  • Field medical team makeup and reporting
  • Product launch activities in which affiliate/country level team takes part in
  • Timing of affiliate/country level teams’ involvement in product launch activities

Field Based Staff: Responsibilities & Compliance
  • Level of MSL interaction: monthly goal vs. actual number of interactions by MSLs (face to face and virtual)
  • MSL responsibilities
  • Platform for documenting interactions with healthcare professionals (HCPs)
  • Requirements for documenting interactions with HCPs
  • Frequency of are compliance checks done in regards to documenting interactions with thought/key opinion leaders, monitoring responsibility and steps taken when there are issues of non-compliance in regards to documenting interactions with thought/key opinion leaders

Field Based Staff: Measuring Performance & Virtual Interactions
  • Metrics used to track the performance of field medical/MSL staff
  • How medical information inquiries are handled
  • Key performance indicators (KPIs) or metrics used to track the performance in medical information function
  • Use of virtual platforms used by MSLs
  • Plans to expand virtual interactions
  • Number of company sponsored clinical studies and investigator initiated studies being conducted annually